Filing Details
- Accession Number:
- 0000711377-16-000075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-02 18:50:42
- Reporting Period:
- 2016-07-29
- Filing Date:
- 2016-08-02
- Accepted Time:
- 2016-08-02 18:50:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189021 | Edward Bradley | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-07-29 | 4,200 | $23.07 | 126,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-07-29 | 4,200 | $55.45 | 122,530 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-08-01 | 15,996 | $23.07 | 138,526 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-08-01 | 15,996 | $55.65 | 122,530 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock ( Right to Buy) | Disposition | 2016-07-29 | 4,200 | $0.00 | 4,200 | $23.07 |
Common Stock | Common Stock (Right to buy) | Disposition | 2016-08-01 | 15,996 | $0.00 | 15,996 | $23.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
133,052 | 2016-09-29 | No | 4 | M | Direct | |
117,056 | 2016-09-29 | No | 4 | M | Direct |
Footnotes
- Options were granted on 9/29/2011, have five year lives, and vest in equal 20% installments on each anniversary date of the grant